Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Gazprom expects strong financial results in 2023

12/19/23 GAZP

Gazprom's capex in 2024 will decrease by 20%

12/19/23 GAZP

Moscow Exchange to suspend trading in IMCB shares for split trading

12/19/23 GEMA

Yandex and Sechenov University have created a medical data platform

12/19/23 YNDX

Rusal started preparations for modernization of KrAZ

12/19/23 RUAL

Mosgorlombard IPO may go for a lower bound of ₽3.1 per share

12/19/23 MGKL

European Union to extend slab import authorization until 2028

12/19/23 NLMK

Sakhalin-2 will continue to supply oil without observing the price ceiling

12/19/23 GAZP

Unlocking Hong Kong shares on SPB Exchange may happen faster

12/19/23 SPBE

SPB Exchange agrees on asset unblocking strategy

12/19/23 SPBE